News Conference News TCT 2020 EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI L.A. McKeown October 22, 2020
News Conference News ACC 2019 Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI Yael L. Maxwell March 18, 2019
News Conference News SCAI 2018 Interventional Appetite Erodes for Dissolving Polymers and Scaffolds Shelley Wood May 04, 2018
News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Conference News TCT 2015 TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years October 14, 2015
News Conference News TCT 2015 TUXEDO-India Affirms Superiority of EES in Patients With Diabetes Todd Neale October 14, 2015
News Conference News TCT 2015 ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES Yael L. Maxwell October 12, 2015
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Conference News ESC 2015 ABSORB Trials Pit BRS Against Second-Generation DES Caitlin E. Cox September 02, 2015
News Conference News EuroPCR 2015 Trials Explore the Potential of Biodegradable-Polymer Stents Caitlin E. Cox May 21, 2015
News Conference News AHA 2014 Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts November 18, 2014
News Conference News TCT 2014 ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES Yael L. Maxwell September 14, 2014
News Conference News TCT 2014 COMPARE II: BES, EES Show Similar Outcomes at Three Years September 13, 2014
News Conference News ESC 2014 BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial Yael L. Maxwell September 01, 2014
News Conference News EuroPCR 2014 BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions Caitlin E. Cox May 21, 2014
News Conference News EuroPCR 2014 CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device Caitlin E. Cox May 20, 2014
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Conference News ACC 2014 NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus Jason Kahn March 31, 2014
News Conference News TCT 2013 Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit November 03, 2013
News Conference News TCT 2013 LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD October 30, 2013